Therapeutic Areas
Endocrine and Metabolic Disease
Overcoming complexities to advance your endocrine and metabolic disease treatments to market rapidly
Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy. At Veristat, we have assembled an extraordinary team of scientific-minded experts who have mastered the complexities of running metabolic disease trials. In the past five years, our team has supported 200+ projects for endocrine/metabolic disorder treatments and prepared nearly 40 marketing applications.
Developing endocrine or metabolic therapy?
Case Study: Flexibility Drives Progress During a Rare Disease Gene Therapy Clinical Trial
Veristat was engaged by a biotech organization focusing on gene therapies for metabolic diseases to support their clinical study for the treatment of a rare human genetic lysosomal storage disorder. Through a collaborative partnership and a flexible operating model, we addressed critical patient, lab, product manufacturing, logistics, and tracking/reporting requirements to satisfy our Sponsor’s requirements at every milestone.
Common Indications
- Diabetes (Type 1 and 2)
Menopause - NASH
Obesity
Polycystic Ovary Syndrome
and more...
Rare Indications
- Adrenoleukodystrophy
Bardet-Biedl Syndrome
Fabry Disease
Gaucher Disease
Lysosomal Acid Lipase Deficiency
Pompe Disease
and many more...
Pediatric Indications
- Cerebral Adrenoleukodystrophy
- Duchenne Muscular Dystrophy
Limb-girdle Muscular Dystrophy
Myotonic Dystrophy
X-linked Myotubular Myopathy
and more...
